Marksans Pharma Dividends and Buybacks
Dividend criteria checks 3/6
Marksans Pharma is a dividend paying company with a current yield of 0.19% that is well covered by earnings.
Key information
0.2%
Dividend yield
0.05%
Buyback Yield
| Total Shareholder Yield | 0.2% |
| Future Dividend Yield | 1.1% |
| Dividend Growth | 5.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ₹0.600 |
| Payout ratio | 9% |
Recent dividend and buyback updates
Recent updates
Is Now The Time To Put Marksans Pharma (NSE:MARKSANS) On Your Watchlist?
Oct 24
Optimistic Investors Push Marksans Pharma Limited (NSE:MARKSANS) Shares Up 45% But Growth Is Lacking
Sep 21Marksans Pharma Limited (NSE:MARKSANS) Stock Rockets 26% But Many Are Still Ignoring The Company
Jul 28Solid Earnings May Not Tell The Whole Story For Marksans Pharma (NSE:MARKSANS)
Jun 07Does Marksans Pharma (NSE:MARKSANS) Deserve A Spot On Your Watchlist?
May 31Sentiment Still Eluding Marksans Pharma Limited (NSE:MARKSANS)
Feb 16Here's Why Marksans Pharma (NSE:MARKSANS) Has Caught The Eye Of Investors
Jan 26We Think Marksans Pharma (NSE:MARKSANS) Can Manage Its Debt With Ease
Dec 02Marksans Pharma (NSE:MARKSANS) Seems To Use Debt Quite Sensibly
Jun 21Robust Earnings May Not Tell The Whole Story For Marksans Pharma (NSE:MARKSANS)
Nov 17This Is The Reason Why We Think Marksans Pharma Limited's (NSE:MARKSANS) CEO Deserves A Bump Up To Their Compensation
Sep 16Marksans Pharma (NSE:MARKSANS) Is Increasing Its Dividend To ₹0.25
Sep 01Marksans Pharma (NSE:MARKSANS) Could Easily Take On More Debt
Jun 14Is Now The Time To Put Marksans Pharma (NSE:MARKSANS) On Your Watchlist?
May 27Is Marksans Pharma (NSE:MARKSANS) A Risky Investment?
Feb 19Marksans Pharma Limited's (NSE:MARKSANS) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Feb 04Here's Why We Think Marksans Pharma (NSE:MARKSANS) Is Well Worth Watching
Jan 20Do Institutions Own Marksans Pharma Limited (NSE:MARKSANS) Shares?
Jan 05
Shareholders Are Thrilled That The Marksans Pharma (NSE:MARKSANS) Share Price Increased 250%
Dec 21What Can We Conclude About Marksans Pharma's (NSE:MARKSANS) CEO Pay?
Dec 06Stability and Growth of Payments
Fetching dividends data
Stable Dividend: MARKSANS's dividend payments have been volatile in the past 10 years.
Growing Dividend: MARKSANS's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Marksans Pharma Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (MARKSANS) | 0.2% |
| Market Bottom 25% (IN) | 0.3% |
| Market Top 25% (IN) | 1.1% |
| Industry Average (Pharmaceuticals) | 0.7% |
| Analyst forecast (MARKSANS) (up to 3 years) | 1.1% |
Notable Dividend: MARKSANS's dividend (0.19%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.25%).
High Dividend: MARKSANS's dividend (0.19%) is low compared to the top 25% of dividend payers in the Indian market (1.14%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (8.7%), MARKSANS's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (52.3%), MARKSANS's dividend payments are covered by cash flows.